The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111)

Biochemical Pharmacology

Volumn 53, Issue 7, 1997, Pages 1005-1012

  Van Pelt, J P A ^a   De Jong, Elke M G J ^a   Van Erp, Piet E J ^a   Mitchell, Malcolm I ^b   Marder, Philip ^b   Spaethe, Stephen M ^b   Van Hooijdonk, Candida A E M ^a   Kuijpers, Astrid L A ^a   Van De Kerkhof, Peter C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

inflammation; integrins, leukotriene B4; LY293111; neutrophils; skin

Indexed keywords

2 [2 PROPYL 3 [3 [2 ETHYL 4 (4 FLUOROPHENYL) 5 HYDROXYPHENOXY]PROPOXY]PHENOXY]BENZOIC ACID; CD11 ANTIGEN; LEUKOTRIENE B4;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; INFLAMMATION; LEUKOCYTE ADHERENCE; MALE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN INFLAMMATION;

EID: 0030920811     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00884-2     Document Type: Article

References (33)

1. Ford-Hutchinson AW and Rackman A, Leukotrienes as mediators of skin inflammation. Br J Dermatol 109: 26-29, 1983.
2. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME and Smith MJH, Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286: 264-265, 1980.
3. Van de Kerkhof PCM and Chang A, Migration of polymorphonuclear leukocytes in psoriasis. Skin Pharmacol 2(3): 138-154, 1989.
4. Lewis RA, Austen KF and Soberman RJ, Leukotrienes and other products of the 5-lipoxygenase pathway. N Engl J Med 323: 645-655, 1990.
5. Kragballe K and Herlin T, Benoxaprofen improves psoriasis. Arch Dermatol 119: 548-552, 1983.
6. Black AK, Camp RDR, Derm FF, Mallet Al, Cunningham FM, Hofbauer M and Greaves MW, Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor in psoriasis. J Invest Dermatol 95: 50-54, 1990.
7. Rask-Madsen J, Bukhave K, Laursen LS, Lauritsen K, 5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease. [Special conference issue]. Agents Actions C37-C45, 1992.
8. McFadden ER and Gilber IA, Asthma. N Engl J Med 327: 1928-1937, 1992.
9. Wardlaw AJ, Hay H and Cromwell O, Leukotrienes LTC4 and LTB4 in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 84(1): 19-26, 1989.
10. 4 by colonie mucosa in inflammatory bowel disease. Gastroenterology 86: 453-460, 1984.
11. Schroeder JM, Inflammatory mediators and chemoattractants. Clin Dermatol 13: 137-150, 1995.
12. Tonnessen MG, Neutrophil-endothelial cell interactions: Mechanisms of neutrophil adherence to vascular endothelium. J Invest Dermatol 93: 53S-58S, 1989.
13. Springer TA, Adhesion receptors of the immune system. Nature 346: 425-434, 1990.
14. Osborn L, Leukocyte adhesion to endothelium in inflammation. Cell 62: 3-6, 1990.
15. Anderson DC, Leukocyte adhesion deficiency: An inherited defect in the Mac-1; LFA-1, and p150,95 glycoproteins. Annu Rev Med 38: 175-194, 1987.
16. Ruoslathi E, Integrins. J Clin Invest 87: 1-5, 1991.
17. Diamond MS, Staunton DE, de Fougerolles AR, Stacker SA, Garcia-Aguilar J, Hibbs ML and Springer TA, ICAM-1 (CD54): A counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 111: 3129-3139, 1990.
18. Griffiths CEM, Voorhees JJ and Nickoloff BJ, Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 20: 617-629, 1989.
19. De Jong EMGJ, van Erp PEJ, van Vlijmen IMJJ and van de Kerkhof PCM, The interrelation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene B4: An immunohistochemical study. Clin Exp Dermatol 7: 413-420, 1992.
20. 4 receptor antagonist. Biochem Pharmacol 49: 1683-1690, 1995.
21. Furie MB, Tancinco MCA and Smith CW, Monoclonal antibodies to leukocyte integrins CD11a/CD18 and CD11b/ CD18 or intercellular adhesion molecule-1 inhibit chemoattractant-stimulated neutrophil transendothelial migration in vitro. Blood 78: 2089-2097, 1991.
22. Vedder NB and Harlan JM, Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J Clin Invest 81: 676-682, 1988.
23. Lowe PM, Lee ML, Jackson CJ, To SST, Cooper AJ and Schrieber L, The endothelium in psoriasis. Br J Dermatol 132: 497-505, 1995.
24. Singer KH, Tuck DT, Sampson HA and Hall RP, Epidermal keratinocytes express the adhesion molecule intercellular adhesion-molecule-1 in inflammatory dermatoses. J Invest Dermatol 92: 746-750, 1989.
25. Boehncke WH, Kellner I, Konter U and Sterry W, Differential expression of adhesion molecules on infiltrating cells in inflammatory dermatoses. J Am Acad Dermatol 26: 907-913, 1992.
26. Hale LP, Martin ME and McCollum DE, Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment. Arthritis Rheum 32: 22-30, 1989.
27. Paukkonen K, Naukkarinen A and Horsmanheimo M, The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes. Arch Dermatol Res 287: 165-170, 1995.
28. Terui T, Zhen YX, Kato T and Tagami H, Mechanism of human polymorphonuclear leukocyte adhesion to serum treated corneocytes. J Invest Dermatol 104: 297-301, 1995.
29. Hartman KR and Wright DG, Identification of autoantibodies specific for the neutrophil adhesion glycoproteins CD11b/ CD18 in patients with auto-immune neutropenia. Blood 78: 1096-1104, 1991.
30. Wu X, Pippin J and Lefkowith JB, Attenuation of immunemediated glomerulonephritis with an anti-CD11b monoclonal antibody. Am J Physiol 264: F715-721, 1993.
31. Doi F, Goya T and Torisu M, Potential role of hepatic macrophages in neutrophil mediated liver injury in rats with sepsis. Hepatology 17: 1086-1094, 1993.
32. Voorhees JJ, Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses. Arch Dermatol 119: 541-547, 1983.
33. De Jong EMGJ and van de Kerkhof PCM, Simultaneous assessment of inflammation and epidermal proliferation in psoriatic plaques during treatment with the new vitamin D3 analogue MC903: Modulations and interrelations. Br J Dermatol 124: 221-229, 1991.